These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6850649)

  • 1. Patterned distribution of metastases from malignant melanoma in humans.
    de la Monte SM; Moore GW; Hutchins GM
    Cancer Res; 1983 Jul; 43(7):3427-33. PubMed ID: 6850649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic patterns in autopsy cases of cutaneous melanoma.
    Akslen LA; Heuch I; Hartveit F
    Invasion Metastasis; 1988; 8(4):193-204. PubMed ID: 3170114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is surgical therapy of distant metastases of malignant melanoma worthwhile?].
    Göhl J; Meyer T; Haas C; Altendorf-Hofmann A; Hohenberger W
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():122-6. PubMed ID: 9101809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic distribution in malignant melanoma. A 30-year autopsy study.
    Akslen LA; Hove LM; Hartveit F
    Invasion Metastasis; 1987; 7(5):253-63. PubMed ID: 3679740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma.
    Starz H; Balda BR; Krämer KU; Büchels H; Wang H
    Cancer; 2001 Jun; 91(11):2110-21. PubMed ID: 11391592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous regression of metastases from malignant melanoma: a case report.
    Kalialis LV; Drzewiecki KT; Mohammadi M; Mehlsen AB; Klyver H
    Melanoma Res; 2008 Aug; 18(4):279-83. PubMed ID: 18626313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Longitudinal study of different metastatic patterns in the progression of cutaneous melanoma].
    Tejera-Vaquerizo A; Barrera-Vigo MV; Fernández-Canedo I; Blázquez-Sánchez N; Mendiola-Fernández M; Fernández-Orland A; Bosch-García R; de Troya-Martín M; Herrera-Ceballos E
    Actas Dermosifiliogr; 2007 Oct; 98(8):531-8. PubMed ID: 17919427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
    Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
    Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
    Karbowniczek M; Chosia M; Domagała W
    Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma.
    Richtig E; Ludwig R; Kerl H; Smolle J
    Br J Dermatol; 2005 Nov; 153(5):925-31. PubMed ID: 16225601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis and staging in melanoma.
    Garrison M; Nathanson L
    Semin Oncol; 1996 Dec; 23(6):725-33. PubMed ID: 8970594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
    Tas F; Kurul S; Camlica H; Topuz E
    Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U; Buettner PG; Eigentler TK; Garbe C
    J Clin Oncol; 2004 Sep; 22(18):3660-7. PubMed ID: 15302905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric prospective study on the prevalence of sublevel IIb metastases in head and neck cancer.
    Villaret AB; Piazza C; Peretti G; Calabrese L; Ansarin M; Chiesa F; Pellini R; Spriano G; Nicolai P
    Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):897-903. PubMed ID: 17875856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.